|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 16
Zeitschriftenartikel
Schettini, Francesco; Venturini, Sergio; Giuliano, Mario; Lambertini, Matteo; Pinato, David J.; Onesti, Concetta Elisa; De Placido, Pietro; Harbeck, Nadia; Lueftner, Diana; Denys, Hannelore; Dam, Peter van; Arpino, Grazia; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne; Bartsch, Rupert; Cortes, Javier; Paris, Ida; Martin, Miguel; De Placido, Sabino; Del Mastro, Lucia; Jerusalem, Guy; Curigliano, Giuseppe; Prat, Aleix und Generali, Daniele
(2022):
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer.
In: Cancer Treatment Reviews, Bd. 111, 102468
Corti, Chiara; Antonarelli, Gabriele; Valenza, Carmine; Nicolo, Eleonora; Rugo, Hope; Cortes, Javier; Harbeck, Nadia; Carey, Lisa A.; Criscitiello, Carmen und Curigliano, Giuseppe
(2022):
Histology-agnostic approvals for antibody-drug conjugates in solid tumours: is the time ripe?
In: European Journal of Cancer, Bd. 171: S. 25-42
Bruzas, Simona; Gluz, Oleg; Harbeck, Nadia; Schmid, Peter; Cortes, Javier; Blohmer, Jens; Seiberling, Christine; Chiari, Ouafaa; Harrach, Hakima; Ataseven, Beyhan; Shenoy, Satyendra; Dyson, Mark H.; Traut, Eugen; Theuerkauf, Ingo; Gebauer, Daniel; Kuemmel, Sherko und Reinisch, Mattea
(2022):
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response.
In: Npj Breast Cancer, Bd. 8, Nr. 1, 42
Monti, Manuela; Degenhardt, Tom; Brain, Etienne; Würstlein, Rachel; Argusti, Alessandra; Puntoni, Matteo; Rollandi, Gian Andrea; Corradengo, Davide; Boni, Luca; Ilhan, Harun; Nanni, Oriana; Cortes, Javier; Piris-Gimenez, Alejandro; Piccardo, Arnoldo; Iacozzi, Massimiliano; Matteucci, Federica; Di Iorio, Valentina; Alberini, Jean Louis; Schroeder, Carolien; Harbeck, Nadia und Gennari, Alessandra
(2022):
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study.
In: Frontiers in Medicine, Bd. 8, 817678
Onesti, Concetta Elisa; Tagliamento, Marco; Curigliano, Giuseppe; Harbeck, Nadia; Bartsch, Rupert; Wildiers, Hans; Tjan-Heijnen, Vivianne; Martin, Miguel; Rottey, Sylvie; Generali, Daniele; Campone, Mario; Cristofanilli, Massimo; Pusztai, Lajos; Peeters, Marc; Berchem, Guy; Cortes, Javier; Ruhstaller, Thomas; Ciruelos, Eva; Rugo, Hope S. und Jerusalem, Guy
(2021):
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology.
In: Jco Global Oncology, Bd. 7: S. 162-172
O'Shaughnessy, Joyce; Schwartzberg, Lee; Piccart, Martine; Rugo, Hope S.; Yardley, Denise A.; Cortes, Javier; Untch, Michael; Harbeck, Nadia; Wright, Gail S.; Bondarenko, Igor; Glaspy, John; Nowecki, Zbigniew; Kayali, Fadi; Chan, Arlene; Levy, Christelle; Liu, Mei-Ching; Kim, Sung-Bae; Lemieux, Julie; Manikhas, Alexey; Tolaney, Sara; Lim, Elaine; Gombos, Andrea; Stradella, Agostina; Pegram, Mark; Fasching, Peter; Mangel, Laszlo; Semiglazov, Vladimir; Dieras, Veronique; Gianni, Luca; Danso, Michael A.; Vacirca, Jeff; Kroll, Stew; O'Connell, Joseph; Tang, Kevin; Wei, Thomas und Seidman, Andrew
(2021):
Results From CONTESSA: A Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2-, Hormone Receptor+ Metastatic Breast Cancer Who Have Previously Received a Taxane.
In: Clinical Advances in Hematology & Oncology, Bd. 19, Nr. 2: S. 12-13
Pascual, Tomas; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Pare, Laia; Bermejo, Begona; Morales, Serafin; Amillano, Kepa; Lopez, Rafael; Galvan, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T.; Llombart-Cussac, Antonio; Di Cosimo, Serena; Baselga, Jose; Harbeck, Nadia; Prat, Aleix und Cortes, Javier
(2021):
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.
In: Npj Breast Cancer, Bd. 7, Nr. 1, 145
Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Onesti, Concetta Elisa; Harbeck, Nadia; Lueftner, Diana; Rottey, Sylvie; Dam, Peter A. van; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne C. G.; Cortes, Javier; Locci, Mariavittoria; Paris, Ida; Del Mastro, Lucia; De Placido, Sabino; Martin, Miguel; Jerusalem, Guy; Venturini, Sergio; Curigliano, Giuseppe und Generali, Daniele
(2021):
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer.
In: Cancers, Bd. 13, Nr. 17, 4421
Winer, Eric P.; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Munoz-Couselo, Eva; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Zhou, Xuan; Karantza, Vassiliki; Mejia, Jaime und Cortes, Javier
(2021):
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 4: S. 499-511
Schmid, Peter; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Foukakis, Theodoros; Fasching, Peter A.; Cardoso, Fatima; Untch, Michael; Jia, Liyi; Karantza, Vassiliki; Zhao, Jing; Aktan, Gursel; Dent, Rebecca und O'Shaughnessy, Joyce
(2020):
Pembrolizumab for Early Triple-Negative Breast Cancer.
In: New England Journal of Medicine, Bd. 382, Nr. 9: S. 810-821
Onesti, Concetta Elisa; Rugo, Hope S.; Generali, Daniele; Peeters, Marc; Zaman, Khalil; Wildiers, Hans; Harbeck, Nadia; Martin, Miguel; Cristofanilli, Massimo; Cortes, Javier; Tjan-Heijnen, Vivianne; Hurvitz, Sara A.; Berchem, Guy; Tagliamento, Marco; Campone, Mario; Bartsch, Rupert; De Placido, Sabino; Puglisi, Fabio; Rottey, Sylvie; Müller, Volkmar; Ruhstaller, Thomas; Machiels, Jean-Pascal; Conte, PierFranco; Awada, Ahmad und Jerusalem, Guy
(2020):
Oncological care organisation during COVID-19 outbreak.
In: Esmo Open, Bd. 5, Nr. 4, e000853
Johnston, Stephen R. D.; Harbeck, Nadia; Hegg, Roberto; Toi, Masakazu; Martin, Miguel; Shao, Zhi Min; Zhang, Qing Yuan; Martinez Rodriguez, Jorge Luis; Campone, Mario; Hamilton, Erika; Sohn, Joohyuk; Guarneri, Valentina; Okada, Morihito; Boyle, Frances; Neven, Patrick; Cortes, Javier; Huober, Jens; Wardley, Andrew; Tolaney, Sara M.; Cicin, Irfan; Smith, Ian C.; Frenzel, Martin; Headley, Desiree; Wei, Ran; San Antonio, Belen; Hulstijn, Maarten; Cox, Joanne; O'Shaughnessy, Joyce und Rastogi, Priya
(2020):
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).
In: Journal of Clinical Oncology, Bd. 38, Nr. 34
Cortes, Javier; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Curigliano, Giuseppe; El Saghir, Nagi S.; Cardoso, Fatima; Barrios, Carlos H.; Wagle, Shama; Roman, Javier; Harbeck, Nadia; Eniu, Alexandru; Kaufman, Peter A.; Tabernero, Josep; Garcia-Estevez, Laura; Schmid, Peter und Arribas, Joaquin
(2020):
Enhancing global access to cancer medicines.
In: CA : A Cancer Journal for Clinicians, Bd. 70, Nr. 2: S. 105-124
Harbeck, Nadia; Penault-Llorca, Frederique; Cortes, Javier; Gnant, Michael; Houssami, Nehmat; Poortmans, Philip; Ruddy, Kathryn; Tsang, Janice und Cardoso, Fatima
(2019):
Breast cancer.
In: Nature Reviews Disease Primers, Bd. 5, 66
Yardley, Denise A.; Brufsky, Adam; Coleman, Robert E.; Conte, Pierfranco F.; Cortes, Javier; Glück, Stefan; Nabholtz, Jean-Mark A.; O'Shaughnessy, Joyce; Beck, Robert M.; Ko, Amy; Renschler, Markus F.; Barton, Debora und Harbeck, Nadia
(2016):
Erratum to: Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial (vol 16, pg 575, 2015).
In: Trials
17
[PDF, 357kB]
Yardley, Denise A.; Brufsky, Adam; Coleman, Robert E.; Conte, Pierfranco F.; Cortes, Javier; Glueck, Stefan; Nabholtz, Jean-Mark A.; O'Shaughnessy, Joyce; Beck, Robert M.; Ko, Amy; Renschler, Markus F.; Barton, Debora und Harbeck, Nadia
(2015):
Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.
In: Trials
16:575
[PDF, 1MB]